Weisfeldt, Myron - Johns Hopkins University

个人简介

Dr. Myron Weisfeldt is the Senior Medical Director of Johns Hopkins Technology Ventures. In this position he provides advice on strategies and evaluation of intellectual property of Johns Hopkins faculty. He is also University Distinguished Service Professor. From 2001 to 2014 Dr. Weisfeldt was the William Osler Professor of Medicine and Chairman of the Department of Medicine at Johns Hopkins School of Medicine. He was also Physician-in-Chief of the Johns Hopkins Hospital. Dr. Weisfeldt received a BA and MD from the Johns Hopkins University. He trained in Cardiology at the Massachusetts General Hospital and the National Institutes of Health and from 1975 to 1991, was Director of the Cardiology Division at the Johns Hopkins. From 1991 to 2001, he was Chairman of the Department of Medicine and Samuel Bard Professor of Medicine at the Columbia University College of Physicians and Surgeons and Director of the Medical Service at the Columbia-Presbyterian Campus of the New York Presbyterian Hospital. Dr. Weisfeldt was Chairman of the Cardiology Advisory Board of the National Heart Lung and Blood Institute from 1987 to 1990 and held the position of President of the American Heart Association in 1990. He is a member of the National Academy of Medicine. His research interests have included heart function, age changes in the heart and circulation, and cardiopulmonary resuscitation. Since 2003 he has been study chair for a large-scale ongoing clinical trials network to conduct randomized definitive trials of devices, drugs and other therapies for out-of-hospital cardiac arrest and severe traumatic injury sponsored by NHLBI and others. This network is called Resuscitation Outcomes Consortium and is now on no cost extension.

研究领域

Cardiopulmonary Resuscitation; Sudden Death

近期论文

查看导师最新文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Weisfeldt ML, Wright JR, Shreiner DP, Lakatta EG, Shock NW: Coronary flow and oxygen extraction in perfused hearts of senescent male rats. J. Appl. Physiol. 30:44‑49, 1971. Lakatta EG, Gerstenblith G, Angell CS, Shock NW, Weisfeldt ML: Diminished inotropic response to aged myocardium to catecholamines. Circ. Res. 36:262‑269, 1975. Weiss JL, Frederiksen JW, Weisfeldt ML: Hemodynamic determinants of the time course of fall in canine left ventricular response. J. Clin. Invest. 58:751‑760, 1976. Gerstenblith G, Lakatta EG, Weisfeldt ML: Age change in myocardial function and exercise response. Prog. Cardiovasc. Dis. 19:1‑21, 1976. Templeton GH, Platt MR, Willerson JT, Weisfeldt ML: Influence of aging left ventricular hemodynamic and stiffness in beagles. Circ. Res. 44(2):189‑194, 1977. Taylor GJ, Tucker WM, Greene HL, Rudikoff MT, Weisfeldt ML: Importance of prolonged compression during cardiopulmonary resuscitation in man. New Engl. J. Med. 296:1515‑1517, 1977. Gerstenblith G, Frederiksen J, Yin FCP, Fortuin NJ, Lakatta EG, Weisfeldt ML: Echocardiographic assessment of a normal adult aging population. Circulation 56:273‑278, 1977. Spurgeon HA, Thorne PA, Yin FCP, Shock NW, Weisfeldt ML: Increased dynamic stiffness of trabeculae carneae from the senescent rat. Am. J. Physiol. 1:H373‑H378, 1977. Yin FCP, Raizes GS, Guarnieri T, Spurgeon HA, Lakatta EG, Fortuin NJ, Weisfeldt ML: Age associated decrease in ventricular response to hemodynamic stress during beta‑adrenergic blockade. Brit. Heart J. 40:1349‑1355, 1978. Mirowski M, Reid PR, Mower MM, Watkins L, Gott VL, Schauble J, Langer A, Heilman MS, Fischell RE, Weisfeldt ML: Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. New Engl. J. Med. 303:322‑324, 1980. Yin FCP, Weisfeldt ML, Milnor WR: The role of aortic input impedance in the decreased cardiovascular response to exercise with aging in the dog. J. Clin. Invest. 68:28‑38, 1981. Weisfeldt ML, Becker L: Resuscitation after cardiac arrest - A 3-phase time-sensitive model. Commentary: JAMA. 288:23, 3035-3038, 2002. The Public Access Defibrillation Trial Investigators (Weisfeldt ML as a member of the steering committee and writing group): Public-access defibrillation and survival after out-of-hospital cardiac arrest. NEJM. 351:637-646, 2004 Weisfeldt ML, Sitlani CM, Ornato JP, Rea T, Aufderheide TP, Davis D, Dreyer J, Hess EP, Jui J, Maloney J, Sopko G, Powell J, Nichol G, Morrison LJ, and the ROC Investigators: Survival after application of automatic external defibrillators before arrival of the emergency medical system: evaluation in the resuscitation outcomes consortium population of 21 million. JACC.; 55:1713-20, PMID: 20394876, 2010 Weisfeldt ML, Everson-Stewart S, Sitlani C, Rea T, Aufderheide TP, Atkins DL, Bigham B, Brooks SC, Foerster C, Gray R, Ornato JP, Powell J, Morrison LJ and the ROC Investigators: Ventricular tachyarrythmias after cardiac arrest in public versus at home. NEJM. 364:313-321, PMID: 21268723, 2011 Stiell IG, Nichol G, Leroux BG, Rea TD, Ornat JP, Powell J, Christenso J, Callaway CW, Kudenchuk PJ, Aufderheide TP, Idris AH, Daya M, Wang HE, Morrison LJ, Davis D, Andrusiek D,Stephens S, Cheskes S, Schmicker RH, Fowler R, Vaillancourt C, Hostler D, Zive D,Pirrallo RG,Vilke G, Sopko G, Weisfeldt ML, and the Resuscitation Outcomes Consortim (ROC) Investigators. Early versus later rhythm in out-of-hospital cardiac arrest. NEJM. 365:9, 787-797, 2011